This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n11http://localhost/temp/predkladatel/
n18http://linked.opendata.cz/resource/domain/vavai/projekt/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n17http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14110%2F07%3A00019098%21RIV10-MZ0-14110___/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14110%2F07%3A00019098%21RIV10-MZ0-14110___
rdf:type
skos:Concept n17:Vysledek
dcterms:description
Background: Apoptosis plays an important role in normal and malignant lymphopoiesis. Therefore signaling pathways participating in this process are intensively investigated to find their crucial molecules suitable for development and application of new antineoplastic agents. Aims: Based on results of our previous studies and literature search, we selected 9 molecules which play an important role in survival of malignant cells to validate their impact for prediction of outcome in DLBCL. Methods and materials: We studied 46 patients with primary DLBCL.The group consisted of 29 men and 27 women with a median age of 59 years (range, 24-79). Advanced stage (III/IV) was observed in 24 cases (52%) and the distribution according to the IPI was as follows: low risk, 20 cases (44%); low/intermediate risk, 12 (26%); high/intermediate risk 9 (19%); and high risk, 5 (11%). Background: Apoptosis plays an important role in normal and malignant lymphopoiesis. Therefore signaling pathways participating in this process are intensively investigated to find their crucial molecules suitable for development and application of new antineoplastic agents. Aims: Based on results of our previous studies and literature search, we selected 9 molecules which play an important role in survival of malignant cells to validate their impact for prediction of outcome in DLBCL. Methods and materials: We studied 46 patients with primary DLBCL.The group consisted of 29 men and 27 women with a median age of 59 years (range, 24-79). Advanced stage (III/IV) was observed in 24 cases (52%) and the distribution according to the IPI was as follows: low risk, 20 cases (44%); low/intermediate risk, 12 (26%); high/intermediate risk 9 (19%); and high risk, 5 (11%).
dcterms:title
THE IMPACT OF SELECTED CELL SURVIVAL REGULATORS (OF AKT-2, BCL-2, CD29, PKC-DELTA AND SURVIVIN) ON PREDICTION OF CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) THE IMPACT OF SELECTED CELL SURVIVAL REGULATORS (OF AKT-2, BCL-2, CD29, PKC-DELTA AND SURVIVIN) ON PREDICTION OF CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
skos:prefLabel
THE IMPACT OF SELECTED CELL SURVIVAL REGULATORS (OF AKT-2, BCL-2, CD29, PKC-DELTA AND SURVIVIN) ON PREDICTION OF CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) THE IMPACT OF SELECTED CELL SURVIVAL REGULATORS (OF AKT-2, BCL-2, CD29, PKC-DELTA AND SURVIVIN) ON PREDICTION OF CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
skos:notation
RIV/00216224:14110/07:00019098!RIV10-MZ0-14110___
n3:aktivita
n14:P
n3:aktivity
P(NR8335)
n3:cisloPeriodika
S1
n3:dodaniDat
n5:2010
n3:domaciTvurceVysledku
n6:2927551 n6:6760074 n6:5713021 n6:7947429 n6:8638063 n6:6986099
n3:druhVysledku
n15:J
n3:duvernostUdaju
n16:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
425596
n3:idVysledku
RIV/00216224:14110/07:00019098
n3:jazykVysledku
n9:eng
n3:klicovaSlova
Akt; DLBCL; Prognostic factor; Survivin
n3:klicoveSlovo
n4:DLBCL n4:Prognostic%20factor n4:Akt n4:Survivin
n3:kodStatuVydavatele
IT - Italská republika
n3:kontrolniKodProRIV
[D20054C9839B]
n3:nazevZdroje
Haematologica/the hematology journal
n3:obor
n12:FD
n3:pocetDomacichTvurcuVysledku
6
n3:pocetTvurcuVysledku
8
n3:projekt
n18:NR8335
n3:rokUplatneniVysledku
n5:2007
n3:svazekPeriodika
2007
n3:tvurceVysledku
Rejthar, Aleš Vášová, Ingrid Fabian, Pavel Svoboda, Marek Klabusay, Martin Nenutil, Rudolf Radová, Lenka Berkovcová, Jitka
s:issn
0390-6078
s:numberOfPages
2
n11:organizacniJednotka
14110